John Lahart (Dublin South West, Fianna Fail) | Oireachtas source

I have a final question. Mr. Watt's opening statement mentioned biolsimilar medicines and the transfer. Is there any possibility of moving towards switching to biosimilar medicines in a more general way to ensure savings?